Official title: Phase I Clinical Trial of Cell Based Therapy for Duchenne Muscular Dystrophy Summary: This is a single-center, single-arm, interventional phase 1 trial to evaluate the safety and tolerability of local injection of induced pluripotent stem cell (iPSC)- derived CD54+ allogeneic muscle progenitor cells in individuals with Duchenne muscular dystrophy (DMD) Conditions: Duchenne Muscular Dystrophy Study type: INTERVENTIONAL Primary purpose: TREATMENT Phases: PHASE1 Enrollment: 8 (ESTIMATED) Status: RECRUITING Completion: 2027-03-03 (ESTIMATED)
Official title: Phase I Clinical Trial of Cell Based Therapy for Duchenne Muscular Dystrophy
Summary: This is a single-center, single-arm, interventional phase 1 trial to evaluate the safety and tolerability of local injection of induced pluripotent stem cell (iPSC)- derived CD54+ allogeneic muscle progenitor cells in individuals with Duchenne muscular dystrophy (DMD)
Conditions: Duchenne Muscular Dystrophy
Study type: INTERVENTIONAL
Primary purpose: TREATMENT
Phases: PHASE1
Enrollment: 8 (ESTIMATED)
Status: RECRUITING
Completion: 2027-03-03 (ESTIMATED)